To assess visual, refractive, and patient-reported outcomes after bilateral RayOne EMV enhanced monofocal IOL implantation using mild mini-monovision.
Approach:
Design and participants: Retrospective observational study of 25 consecutive patients (50 eyes) who underwent bilateral surgery between December 2022 and April 2024; all had complete Month 6 data.
Target and assessment: The dominant eye was targeted for emmetropia and the non-dominant eye for approximately −0.50 D. Preoperative assessment included refraction, ocular examination, OCT, and optical biometry.
Eligibility: Participants had bilateral cataract surgery with RayOne EMV IOLs, corneal astigmatism ≤1.00 D, and no ocular pathology apart from cataract or prior ocular surgery.
Key Findings:
The supplied source excerpt describes the study objective and methods but is truncated before postoperative outcome results are reported.
Interpretation:
The supplied excerpt establishes the study design and planned mini-monovision targets but does not include postoperative results, so clinical and refractive outcomes cannot be characterized from this material.
Limitations:
The study was retrospective and included 25 patients (50 eyes).
The supplied excerpt is truncated during the Methods section and does not provide postoperative outcome results.
